Product Description
Cell-permeable. An anthracycline antitumor antibiotic. A stereoisomer of doxorubicin (Cat. No. 1527-5) that exhibits reduced cardiotoxicity. Its antitumor actions are mediated by targeting topoisomerase II.
Epirubicin Hydrochloride is an anthracycline antitumor antibiotic. A stereoisomer of doxorubicin (Cat. No. 1527-5) that exhibits reduced cardiotoxicity. Its antitumor actions are mediated by targeting topoisomerase II.
Biovision | 1753 | Epirubicin Hydrochloride DataSheet
Alternate Name/Synonyms: (8S-cis)-10-((3-amino-2,3,6-trideoxy-β-L-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride; 4'-epiadriamycin; 4'-epidoxorubicin
Appearance: Orange-red powder
Formulation: N/A
CAS Number: 56390-09-1
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₇H₂₉NO₁₁ · HCl
Molecular Weight: 579.98
Cell-Permeable?: Yes
Purity: ≥95% by HPLC
Solubilities: H₂O (1 mg/ml)
Handling: Protect from air and moisture
Country of Origin: USA
Tag Line: A DNA topoisomerase II inhibitor
MDL Number: MFCD00941448
PubChem CID: 65348
SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl
InChi: InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22-,27-;/m0./s1
InChi Key: MWWSFMDVAYGXBV-FGBSZODSSA-N